TY - JOUR
T1 - Questions Concerning the Clinical Translation of Cell-Based Interventions under an Innovation Pathway
AU - Sugarman, Jeremy
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2012/12
Y1 - 2012/12
N2 - Stem cell-based innovation is one pathway to clinical translation that stands in contrast to clinical research and medical treatment. After reviewing recently issued guidelines for responsible innovation, this article examines the potential benefits and harms of using this pathway as well as practical barriers and conceptual concerns regarding it.
AB - Stem cell-based innovation is one pathway to clinical translation that stands in contrast to clinical research and medical treatment. After reviewing recently issued guidelines for responsible innovation, this article examines the potential benefits and harms of using this pathway as well as practical barriers and conceptual concerns regarding it.
UR - http://www.scopus.com/inward/record.url?scp=84872162721&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872162721&partnerID=8YFLogxK
U2 - 10.1111/j.1748-720X.2012.00723.x
DO - 10.1111/j.1748-720X.2012.00723.x
M3 - Article
C2 - 23289697
AN - SCOPUS:84872162721
SN - 1073-1105
VL - 40
SP - 945
EP - 950
JO - Journal of Law, Medicine and Ethics
JF - Journal of Law, Medicine and Ethics
IS - 4
ER -